Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success
November 27, 2025 | Campaign planning, Protocol consulting, R:SQD, Study rescue, clinical trials
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
R:SQD, a groundbreaking recruitment and retention success scoring tool that gives clinical trial sponsors the evidence, insight, and confidence to design and deliver truly participant-centred studies, has launched today.
By blending trial data with patient insights, R:SQD delivers a clear, evidence-based score showing how ready a trial is to attract, recruit, and retain participants, as well as providing tailored recommendations to strengthen engagement and protect trial outcomes.
A new kind of trial health check
R:SQD provides a rapid, evidence-based assessment of how participant-ready a study really is. Its unique scoring system reveals the barriers that may be limiting recruitment or driving dropouts, while expert-driven recommendations help sponsors act early, remove friction, and build trust with participants.
“When recruitment slows or retention drops, it can be hard to see what’s really holding a trial back,” said Stacey Davidson, Head of Strategy and Content at Cuttsy+Cuttsy. “R:SQD cuts through the noise, combining data and empathy to deliver clarity, confidence, and practical next steps. It’s about turning insight into action – helping today’s trials become tomorrow’s breakthroughs.”
Supporting every stage of the trial journey
R:SQD is designed to add value across the full trial lifecycle, whether teams are rescuing an underperforming study, planning a launch, or designing a protocol.
- Study rescue: When a trial is struggling, R:SQD delivers a rapid health check and recovery plan, pinpointing participant-experience fail points and guiding sponsors to regain momentum, protect timelines, and rebuild engagement.
- Campaign planning: Ahead of launch, R:SQD predicts how ready a study is to support participants from day 1. Its readiness score and activation blueprint help leaders allocate resources effectively, identify risks early, and ensure every new trial starts strong.
- Protocol consulting: By reviewing draft protocols through a participant lens, R:SQD highlights where complexity or burden could affect enrolment and retention, helping teams design trials that are not only scientifically robust but also patient-ready and practical in the real world.
Turning data into difference
Unlike traditional analytics platforms, R:SQD blends quantitative insight with human understanding. Its tailored recommendations provide clear, evidence-based actions that make trials more inclusive, efficient, and participant friendly.
“R:SQD reflects our belief that people should be at the heart of every clinical trial,” said Mathew Cutts, Co-Founder and Director of Cuttsy+Cuttsy. “By giving sponsors the tools to see, understand, and address the real barriers to participation, we can help create studies that deliver better experiences and better results.”
Ready to give your trial a health check?
R:SQD is now available to pharmaceutical companies, CROs, and research organisations seeking to strengthen recruitment, retention, and participant engagement strategies.
Discover how R:SQD can put your trial on track for success. Talk to our team.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People
Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.
Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating
Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...
Age is not just a number when it comes to clinical trials
In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...
How to boost clinical trial access and make patients health-empowered
Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
Closing the loop: Why clinical trial results matter to participants
Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.
Unveiling the truth: A journey into women’s representation in clinical trials
We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.
Clarity in clinical trials
Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.
Caring for patients’ mental health in clinical trials
We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.
Driving equitable healthcare: The role of DE&I in clinical trials
Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...
Empowering patients through more accessible clinical trial information
Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...